Metformin

Treatment for Long Covid

Typical Dosage: 500mg twice daily for 10-14 days (acute), or 500-1000mg daily for Long COVID

Effectiveness
45%
Safety Score
65%
Clinical Trials
2
Participants
3.5K

Comparative Safety Scale(Higher is safer)

Cyanideโ˜ ๏ธ
Meth๐Ÿ’€
Cigarettes๐Ÿšฌ
Chemoโ˜ข๏ธ
Alcohol๐Ÿบ
Morphine๐Ÿ’Š
Antibiotics๐Ÿ’‰
Tylenol๐Ÿ’Š
Exercise๐Ÿƒ
Water๐Ÿ’ง
65
DangerousModerateSafe
Treatment Details
Dosage Range
500mg twice daily for 10-14 days (acute), or 500-1000mg daily for Long COVID
Time to Effect
Weeks to months
Treatment Duration
10-14 days (acute prevention), several months (for existing Long COVID)
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
18(Treat 18 patients to see 1 additional successful outcome)
Confidence Score
55%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$120
Monitoring:$100
Side Effect Mgmt:$50
Total Annual:$270
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$900
Metformin Outcomes

for Long Covid

Efficacy Outcomes
Overall Effectiveness
+45%
Response Rate
+30%
Common Side Effects
Diarrhea
+25%
Nausea/Vomiting
+12%
Abdominal discomfort
+8%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
2 active trials recruiting for Metformin in Long Covid

Effect of Metformin in Reducing Fatigue in Long COVID in Adolescents

NCT06147050NOT YET RECRUITINGPHASE3
View Study
16 participants
INTERVENTIONAL
Karachi, Pakistan
Started: Apr 1, 2024

RECLAIM Adaptive Platform Trial for PCC Treatments

NCT07280572ENROLLING BY INVITATIONPHASE3
View Study
1.25K participants
INTERVENTIONAL
Utrecht, Netherlands
Started: Feb 17, 2025